Is it possible for a mother with AB positive blood type to have a child with A negative blood type, and does this require any specific medical intervention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

AB Positive Mother with A Negative Child: Genetics and Clinical Management

Yes, it is entirely possible for an AB positive mother to have an A negative child, and this requires no specific medical intervention beyond standard newborn care and monitoring for ABO hemolytic disease of the fetus and newborn (HDFN).

Genetic Explanation

This blood type combination is genetically straightforward and does not represent an incompatibility requiring intervention:

  • An AB positive mother carries one A allele and one B allele, with at least one Rh-positive (D) gene
  • The father must carry an O allele (to produce the A blood type in the child) and be Rh-negative or carry a recessive Rh-negative allele
  • The child inherits the A allele from the mother and an O allele from the father, resulting in blood type A
  • The child inherits Rh-negative alleles from both parents, resulting in Rh-negative status

This is a normal Mendelian inheritance pattern and does not indicate any genetic abnormality or require paternity testing.

Clinical Considerations

ABO Incompatibility Monitoring

The primary clinical concern is ABO HDFN, which can occur when a mother has blood group AB and the infant has blood group A, though this is less common than the classic O mother/A or B infant scenario:

  • Monitor the newborn for jaundice and anemia in the first 24-72 hours of life 1, 2
  • Check direct antiglobulin test (DAT) on cord blood or early newborn sample 2
  • Measure bilirubin levels if clinical jaundice develops 1
  • Most cases are mild and require only phototherapy if treatment is needed 1

Important caveat: While maternal blood group O is most commonly associated with ABO HDFN, cases have been documented with AB mothers having high anti-A titers causing clinically significant hemolysis in type A infants 3. However, this is rare and typically presents with obvious clinical signs.

Rh Status: No Intervention Needed

The Rh incompatibility (mother Rh-positive, baby Rh-negative) requires absolutely no intervention because:

  • Rh disease only occurs when an Rh-negative mother develops antibodies against an Rh-positive fetus 4, 5
  • An Rh-positive mother cannot develop anti-D antibodies against her own antigen
  • The reverse situation (Rh-positive mother, Rh-negative baby) poses no risk to the fetus or newborn
  • No RhIg (Rhogam) is indicated in this scenario 5, 6

Clinical Algorithm

For the newborn:

  1. Perform ABO and Rh typing at birth
  2. Obtain DAT on cord blood
  3. Monitor for clinical jaundice in first 72 hours
  4. If jaundice develops: measure total bilirubin and hemoglobin
  5. Treat with phototherapy if bilirubin exceeds treatment thresholds
  6. Reserve exchange transfusion for severe cases unresponsive to phototherapy 1

For future pregnancies:

  • No special monitoring required beyond standard prenatal care
  • Standard ABO typing and antibody screening at first prenatal visit
  • No increased risk for subsequent pregnancies

Common Pitfalls to Avoid

  • Do not assume this blood type combination is impossible - it follows normal genetic inheritance
  • Do not administer RhIg to an Rh-positive mother - this is unnecessary and wastes a scarce resource 6
  • Do not overlook ABO HDFN monitoring simply because the mother is not blood group O - rare severe cases can occur with AB mothers 3
  • Do not perform unnecessary genetic testing - this is a normal inheritance pattern

Related Questions

In a newborn with ABO incompatibility (mother blood type B positive, infant blood type A positive), what is the recommended evaluation and management?
What is the purpose of collecting ABO (Blood Type) and Rh (Rhesus) blood types in newborns?
How are Rh‑negative maternal alloimmunization, ABO incompatibility, and indirect and direct Coombs testing managed during pregnancy and in the newborn?
What is the interpretation of the eluate results in a Hemolytic Disease of the Fetus and Newborn (HDFN) workup?
In a pregnant woman whose indirect antiglobulin test is positive on panel cells 3 and 11, what is the significance of this finding and how should it be evaluated and managed?
Is the MRSA infection transmissible to healthy individuals?
What is the appropriate treatment regimen for abdominal tuberculosis in a 39-year-old man?
In a patient with ST-elevation myocardial infarction (STEMI) who is already on antiplatelet therapy, should a loading dose of antiplatelet agents be administered again?
What is the appropriate management for a 39‑year‑old woman with primary adrenal insufficiency (Addison’s disease) who has an anal abscess and an elevated 3‑hour troponin‑T level?
How should a prolonged activated partial thromboplastin time (APTT) that corrects with fresh frozen plasma (FFP) be managed?
In a 2‑month‑old infant with markedly elevated liver enzymes, severe neutropenia, normal albumin, normal coagulation studies, and a normal abdominal ultrasound, can viral hepatitis cause myelosuppression reflected in the complete blood count?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.